Introduction
Thrombocytopenia is defined as a platelet count of less than 150 x 109/l. Normal pregnancy is generally thought not to affect the platelet count,' but it has been suggested that the normal range is lower in pregnancy, and that the count falls in the third trimester.2`4 This review concentrates on causes of thrombocytopenia with particular reference to pregnancy: most of these involve excessive platelet consumption (Table I) .
Failure of platelet production
Demand for folic acid rises to 300-400 ytg/day in normal pregnancy, and dietary deficiency may cause thrombocytopenia, particularly where demand is increased by multiple pregnancy, or Aplastic anaemia and paroxysmal nocturnal haemoglobinuria, although rare, do occur in young women, and there is anecdotal evidence for an association of both with pregnancy. 6 Colvin reviews other coincidental causes, such as congenital thrombocytopenias, and malignancies.6
Excessive platelet consumption This is observed in idiopathic (auto-immune) thrombocytopenia (ITP), pre-eclampsia/eclampsia, disseminated intravascular coagulopathy (DIC), and thrombotic thrombocytopenia purpura (TTP). Accelerated platelet activation and consumption characterize normal pregnancy,7'8 which may partly explain the common finding of mild thrombocytopenia (platelets 100-150 x 109/l), known as pregnancy-associated (PAT), gestational asymptomatic or incidental thrombocytopenia.2 '9-12 Idiopathic thrombocytopenic purpura Chronic ITP is a common auto-immune disorder in young women. Platelet-associated IgG (PAIgG) is detected in over 90% of cases, and circulating anti-platelet antibodies in about 50%. These are not specific for ITP, however, occurring also in pre-eclampsia, PAT, and possibly in normal pregnancy.2"'5 In 95% of cases the antibody class is IgG, and 90% of these are IgG,,'6 which can cross the placenta. The antibodies are often directed against glycoproteins Ilb, Illa or lb.'7 ITP may complicate 20% of pregnancies in women with systemic lupus erythematosus'8 (reviewed by de Swiet),'9 and may be the presenting feature in 5-10% of cases of human immunodeficiency virus (HIV) infection. 20 Management must address the possibility of fetal involvement. Anti-platelet IgG may cross the placenta and cause thrombocytopenia, which if severe (less than 50 x 109/1) carries a high risk of Pre-eclampsia and pregnancy-induced hypertension Thrombocytopenia occurs in 17-50% of preeclamptic women,'3"57-60 and may precede the development ofhypertension, or occur without it.6' There is increasing evidence of the pivotal role of platelets in the development of pre-eclampsia and intra-uterine growth retardation,62'63 and of the effectiveness of anti-platelet agents in preventing these.' Platelet lifespan is reduced,65 and activation increased as shown by raised beta-thromboglobulin levels.66 Changes in platelet calcium flux may be detectable as early as the first trimester in women who later develop pre-eclampsia.62 Overt DIC is uncommon, and standard coagulation assays are usually normal, but platelet dysfunction59'67-69 may be reflected by a prolonged bleeding time.54'69 '70 The treatment for progressive pre-eclampsia, including thrombocytopenia, remains delivery, and the thrombocytopenia then rapidly resolves.60 The ongoing CLASP trial should determine whether low-dose aspirin can prevent pre-eclampsia, which would represent a major advance in managing this problem.
The HELLP syndrome (haemolysis, elevated liver function tests, low platelet counts) is a serious complication of pre-eclampsia,71 affecting about 8.5% of severe pre-eclamptics,58 and perinatal mortality may approach 50%. It is vital to recognize the syndrome, even in the absence of marked hypertension, as recovery may necessitate immediate delivery, despite fetal immaturity.7'72 Following delivery, the illness regresses rapidly. Close monitoring of a stable patient may allow fetal maturation.7'
Infants of pre-eclamptic women are unlikely to be thrombocytopenic, except when they have other complications of prematurity.7475
Thrombotic thrombocytopenic purpurahaemolytic uraemic syndrome TTP is rare, and the cause is unknown. The pentad of features (fever, neurological disturbances, renal impairment, thrombocytopenia and microangiopathic haemolytic anaemia) is due to intravascular platelet clumping. The closely related haemolytic uraemic syndrome usually presents postnatally with acute renal failure.6 TTP has been linked to pregnancy,76 and oral contraceptive medication,6 and there may also be an association with HIV . 7 Prior to 1980 the disease was usually fatal,78 and prompt delivery did not affect the outcome,76 but two recent series with a total of 210 patients report successful treatment of 71% and 91% of cases respectively.77'79 The most effective treatment was plasma exchange with fresh frozen plasma (FFP) replacement, ± high dose prednisone. Nine pregnant women presented with TTP in the third trimester; they all survived and delivered unaffected babies, and five subsequently had normal pregnancies.77 A high molecular weight fraction of FFP, requiring smaller infusion volumes, may also be useful.8" Platelet transfusions are contra-indicated.
Disseminated intravascular coagulopathy
Obstetric problems are important causes of DIC, which may complicate placental abruption, preeclampsia, intra-uterine death or infection, uterine rupture and amniotic fluid embolism. Management is that of the underlying cause, with supportive therapy, including platelet and factor replacement as required. Heparin is advocated in cases where the vascular tree is intact, such as amniotic fluid embolism and the chronic DIC accompanying retention of a dead fetus.8' Heparin is also important in the prevention of gangrene in the rare and serious post-partum complication of Gram-negative septicaemia and DIC, purpura fulminans. 82 DIC and thrombocytopenia are also features of acute fatty liver of pregnancy. The maternal and fetal mortality (both around 80%) in this rare syndrome appear reduced by prompt delivery, and so recognition of impending hepatic and renal failure in the third trimester is vital.268'
Heparin
In 0.6-9% of patients, heparin induces antiplatelet IgG, which can cause thrombocytopenia and thrombosis, often arterial, due to complementmediated platelet activation.84 '85 This action is heparin-dependent, and as heparin does not cross the placenta, the fetus is not affected. It occurs [7] [8] [9] [10] [11] [12] [13] [14] days after the initiation of heparin therapy, and can complicate even low-dose therapy, with significant mortality and risk of amputation. If heparin is unavoidable, heparin from a different source may be safer. 86 Thrombocytopenia during pregnancy has also been reported as complicating mild type lIb von 87, 88 Willebrand's disease, and chorioangioma of the placenta,89 and as spurious due to EDTA-induced platelet clumping.90
Conclusion
Thrombocytopenia is a common finding in pregnancy, and careful diagnosis is important to distinguish serious causes from benign PAT, and to manage the mother and fetus appropriately.
